Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Annals of the Rheumatic Diseases

• Publication date

  2004-11-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/ard.2003.015453PMID 15547090PMCID PMC1754837
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis).

  2010cited by this paper
• Churg-Strauss syndrome.

  2003cited by this paper
• Mortality and morbidity in peripheral neuropathy associated Churg-Strauss syndrome and microscopic polyangiitis.

  2002cited by this paper
• Churg-Strauss syndrome: update on recent developments.

  2002cited by this paper
• Recent Advances in the Diagnosis of Churg-Strauss Syndrome

  2001cited by this paper
• Treatment of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: where do we stand?

  2001cited by this paper
• Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients.

  2001cited by this paper
• Intravenous immunoglobulin treatment in peripheral nerve disorders - indications, mechanisms of action and side-effects

  2000cited by this paper
• Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity.

  2000cited by this paper
• Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases.

  1999cited by this paper
• Clinicopathological features of Churg-Strauss syndrome-associated neuropathy.

  1999cited by this paper
• Marked improvement of Churg-Strauss vasculitis with intravenous gammaglobulins.

  1999cited by this paper
• Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients.

  1999cited by this paper
• Use of Cytotoxic Agents and Cyclosporine in the Treatment of Autoimmune Disease: Part 2: Inflammatory Bowel Disease, Systemic Vasculitis, and Therapeutic Toxicity

  1998cited by this paper
• Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients.

  1996cited by this paper
• Development and standardization of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA). A report on the second phase of an international cooperative study on the standardization of ANCA assays.

  1996cited by this paper
• IL‐1β production by human polymorphonuclear leucocytes stimulated by anti‐neutrophil cytoplasmic autoantibodies: relevance to systemic vasculitis

  1996cited by this paper
• Intravenous immunoglobulin as sole therapy for systemic vasculitis.

  1996cited by this paper
• Treatment of anti‐neutrophil cytoplasmic antibody (ANCA)‐associated systemic vasculitis with high‐dose intravenous immunoglobulin

  1995cited by this paper
• Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis. A prospective, randomized trial in sixty-two patients.

  1995cited by this paper
• Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide.

  1994cited by this paper
• Outcome of polyarteritis nodosa and Churg-Strauss syndrome. An analysis of twenty-five patients.

  1994cited by this paper
• Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

  1994cited by this paper
• Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.

  1994cited by this paper
• ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin.

  1993cited by this paper
• Asthma and vasculitis. Response to intravenous immunoglobulins.

  1993cited by this paper
• Treatment of systemic vasculitis with pooled intravenous immunoglobulin.

  1991cited by this paper
• Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulin.

  1991cited by this paper
• Longterm followup after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange. A prospective randomized trial of 71 patients. The Cooperative Study Group for Polyarteritis Nodosa.

  1991cited by this paper
• Neuroimmune Networks

  1990cited by this paper
• Asthma and vasculitis.

  1989cited by this paper
• Interobserver agreement for the assessment of handicap in stroke patients.

  1989cited by this paper
• Interobserver agreement for the assessment of handicap in stroke patients.

  1988cited by this paper
• The clinical spectrum of necrotizing angiopathy of the peripheral nervous system

  1985cited by this paper
• Allergic granulomatosis, allergic angiitis, and periarteritis nodosa.

  1951cited by this paper

• Intravenous immunoglobulin in rheumatology: new data and draft clinical guidelines

  2025cites this paper
• Vasculitic neuropathy-related disability, pain, quality of life, and autonomic symptoms: A survey of 312 patients.

  2024cites this paper
• Biological Effects and Clinical Application of the Anti-Immunoglobulin E Antibody

  2024cites this paper
• Effectiveness and safety of intravenous immunoglobulin for peripheral neuropathy in EGPA patients: a retrospective study

  2024cites this paper
• Eosinophilic granulomatosis with polyangiitis

  2022cites this paper
• Intravenous Immunoglobulin Therapy

  2021cites this paper
• Novel Targets for Drug Use in Eosinophilic Granulomatosis With Polyangiitis

  2021cites this paper
• The therapeutic efficacy of intravenous immunoglobulin in anti-neutrophilic cytoplasmic antibody-associated vasculitis: a meta-analysis.

  2020cites this paper
• Normas

  2020cites this paper
• Eosinophilic granulomatosis with polyangiitis: modern view on pathogenesis and treatment (literature review)

  2020cites this paper
• Peripheral Nervous System Involvement.

  2020cites this paper
• Updates for the treatment of EGPA.

  2020cites this paper
• Pulmonary Eosinophilic Granulomatosis with Polyangiitis has IgG4 Plasma Cells and Immunoregulatory Features.

  2020cites this paper
• ANCA associated vasculitis.

  2020cites this paper
• Eosinophilic Vasculitis

  2020cites this paper
• Peripheral Nervous System Involvement

  2019cites this paper
• Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg–Strauss)

  2019cites this paper
• Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis

  2019cites this paper
• Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis

  2019cites this paper
• Eosinophilic granulomatosis with polyangiitis: the multifaceted spectrum of clinical manifestations at different stages of the disease

  2019cites this paper
• Eosinophilic Granulomatosis With Polyangiitis: Newer Therapies

  2018cites this paper
• Eosinophilic Granulomatosis with Polyangiitis: Clinical Pathology Conference and Review.

  2018cites this paper
• Eosinophile Granulomatose und Polyangiitis – Diagnostik und Therapie

  2018cites this paper
• Role of Intravenous Immunoglobulin in Dermatologic Disorders

  2018cites this paper
• Eosinophilic Granulomatosis with Polyangiitis (Churg–Strauss)

  2018cites this paper
• Biologic and Systemic Agents in Dermatology

  2018cites this paper
• 10 Immunoglobulin Treatment in Polymyositis and Dermatomyositis

  2017cites this paper
• S1-Leitlinie Diagnostik und Therapie der ANCA-assoziierten Vaskulitiden

  2017cites this paper
• Intravenous Immunoglobulin: Dermatologic Uses and Mechanisms of Action

  2017cites this paper
• S1-Leitlinie Diagnostik und Therapie der ANCA-assoziierten Vaskulitiden

  2017cites this paper
• Current and Future Treatment Options for Eosinophilic Granulomatosis With Polyangiitis

  2017cites this paper
• Optimal therapy and prospects for new medicines in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)

  2016cites this paper
• [Churg-Strauss syndrome].

  2016cites this paper
• Successful Use of Plasma Exchange in the Treatment of Corticosteroid-Refractory Eosinophilic Granulomatosis with Polyangiitis Associated with Gastrointestinal Manifestations

  2016cites this paper
• Management of Small Vessel Vasculitides

  2016cites this paper
• Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management.

  2015cites this paper
• Factors that predict in‐hospital mortality in eosinophilic granulomatosis with polyangiitis

  2015cites this paper
• Granulomatous vasculitis.

  2015cites this paper
• Intravenous immunoglobulin in critically ill adults: When and what is the evidence?

  2015cites this paper
• Churg-Strauss Syndrome or Eosinophilic Granulomatosis with Polyangiitis

  2015cites this paper
• Churg-Strauss syndrome.

  2015cites this paper
• Intravenous Immunoglobulin as an Immunomodulating Agent in Antineutrophil Cytoplasmic Antibody–Associated Vasculitides: A French Nationwide Study of Ninety‐Two Patients

  2015influential citation
• Intravenous immunoglobulin for chronic residual peripheral neuropathy in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome): a multicenter, double-blind trial

  2015cites this paper
• Marked improvement of Churg–Strauss syndrome neuropathy by intravenous immunoglobulin and cyclophosphamide

  2014cites this paper
• High-dose intravenous immunoglobulin therapy for eosinophilic granulomatosis with polyangiitis

  2014cites this paper
• Vasculitic Neuropathies and Neuropathies of Connective Tissue Diseases

  2014cites this paper
• Autoimmunity and Sinus Disease

  2014cites this paper
• Effect of delayed diagnosis on disease course and management of Churg–Strauss syndrome: a retrospective study

  2013cites this paper
• Intravenous immunoglobulin therapy in vasculitic ulcers: a case of polyarteritis nodosa

  2013cites this paper
• Assessment of the Birmingham vasculitis activity score in patients with MPO-ANCA-associated vasculitis: sub-analysis from a study by the Japanese Study Group for MPO-ANCA-associated vasculitis

  2013cites this paper
• Krankheitsbilder in der Pneumologie

  2013cites this paper
• Assessment of the Birmingham vasculitis activity score in patients with MPO-ANCA-associated vasculitis: sub-analysis from a study by the Japanese Study Group for MPO-ANCA-associated vasculitis

  2013cites this paper
• Efficacy of early intravenous immunoglobulin for eosinophilic granulomatosis with polyangiitis with drastically progressive neuropathy: a synopsis of two cases.

  2013cites this paper
• Eosinophilic granulomatosis with polyangiitis (Churg–Strauss): state of the art

  2013cites this paper
• The Advantage of Specific Intravenous Immunoglobulin (sIVIG) on Regular IVIG: Experience of the Last Decade

  2012cites this paper
• Effective intravenous immunoglobulin therapy for Churg-Strauss syndrome (allergic granulomatous angiitis) complicated by neuropathy of the eighth cranial nerve: a case report

  2012cites this paper
• Intervenous immunoglobulins as modulators of immune response : effect on T cell polarisation, pathogenicity and trafficking

  2012cites this paper
• Successful treatment of eosinophilic granulomatosis with polyangiitis (EGPA; formerly Churg–Strauss syndrome) with rituximab in a case refractory to glucocorticoids, cyclophosphamide, and IVIG

  2012cites this paper
• Pregnancy and vasculitis: a systematic review of the literature.

  2012cites this paper
• [Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)].

  2012cites this paper
• 23. Eosinophilic Granulomatosis with Polyangiitis (Churg–Strauss Syndrome)

  2012cites this paper
• Admission decisions to a medical intensive care unit are based on functional status rather than severity of illness. A single center experience.

  2012cites this paper
• Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application.

  2011cites this paper
• Churg-Strauss syndrome

  2011cites this paper
• Secondary Glomerular Disease

  2011cites this paper
• A severe form of Churg-Strauss syndrome complicated with acute cardiac failure and rapidly progressive peripheral neuropathy--a possible effect of intravenous immunoglobulin therapy.

  2011cites this paper
• Immunoglobulin Treatment in Polymyositis and Dermatomyositis

  2011cites this paper
• The Etiology, Mechanisms, and Treatment of Churg-Strauss Syndrome

  2011cites this paper
• Intravenous Immunoglobulin Therapy in Primary Vasculitides

  2011cites this paper
• 28-year-old woman with rapidly progressive shortness of breath. Diagnosis: CSS.

  2010cites this paper
• Churg–Strauss syndrome: evidence for disease subtypes?

  2010cites this paper
• Administration of human immunoglobulin suppresses development of murine systemic vasculitis induced with Candida albicans water-soluble fraction: an animal model of Kawasaki disease

  2010cites this paper
• Churg-Strauss syndrome: evolving concepts.

  2010cites this paper
• The role of high-dose intravenous immunoglobulin in rheumatology.

  2010cites this paper
• Diagnostic and therapeutic management of Churg–Strauss syndrome

  2009cites this paper
• Evidence for the Use of Intravenous Immunoglobulins—A Review of the Literature

  2009influential citation
• Churg-Strauss syndrome presenting with diffuse alveolar hemorrhage and rapidly progressive glomerulonephritis.

  2009cites this paper
• Nonsystemic vasculitic neuropathy: update on diagnosis, classification, pathogenesis, and treatment.

  2009cites this paper
• Churg-Strauss angiitis.

  2009cites this paper
• [Churg-Strauss syndrome presenting with cutaneous vasculitis].

  2009cites this paper
• Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients.

  2008cites this paper
• Pathophysiology of Inflammation in the Surgically Failed Sinus Cavity

  2008cites this paper
• A phase II study of interferon-alpha for the treatment of refractory Churg-Strauss syndrome.

  2008cites this paper
• Churg-Strauss syndrome: 2005–2008 update

  2008cites this paper
• ANCA-negative glomerulonephritis associated with nonasthmatic Churg–Strauss syndrome

  2008cites this paper
• Treatment of Churg-Strauss syndrome with an inhaled corticosteroid after oral steroids discontinuation due to side effects.

  2008cites this paper
• Differenzierung zwischen dem Churg-Strauss Syndrom und dem Hypereosinophilen Syndrom anhand eines künstlichen neuronalen Netzwerkes

  2008cites this paper
• Marked improvement of Churg–Strauss vasculitis with intravenous gamma globulins during pregnancy

  2007cites this paper
• The use of i.v. IG therapy in dermatology

  2007cites this paper
• Leflunomide versus methotrexate in Wegener's granulomatosis.

  2007cites this paper
• Development of comprehensive disease assessment in systemic vasculitis

  2007cites this paper
• Roadmap to vasculitis: a rheumatological treasure hunt

  2007cites this paper
• Roadmap to vasculitis: a rheumatological treasure hunt

  2007cites this paper
• Administration of Anti-IgE to a Churg-Strauss Syndrome Patient

  2007cites this paper
• Le immunoglobuline nella terapia delle malattie reumatiche Intravenous immunoglobulin for rheumatic diseases

  2007cites this paper
• Churg–Strauss syndrome

  2007cites this paper
• Treatment for Churg-Strauss syndrome: induction of remission and efficacy of intravenous immunoglobulin therapy.

  2007cites this paper
• Immunosuppressive treatment for non-systemic vasculitic neuropathy.

  2007cites this paper
• Intravenous immunoglobulin in the treatment of resistant subacute cutaneous lupus erythematosus: a possible alternative

  2007cites this paper
• Development of comprehensive disease assessment in systemic vasculitis

  2006cites this paper